Cash, Cash Equivalents, and Short-Term Investments (Tables)

12 Months Ended

Dec. 31, 2023

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

	December 31,
	2023		2022
Cash and Cash Equivalents	$	199,371	$	273,070
Restricted Cash - Current(1)	43,897		40,366
Restricted Cash - Non-current(1)	—		13,516
Cash and Cash Equivalents and Restricted Cash	$	243,268	$	326,952

(1) Restricted Cash - Current is included in Other Current Assets in the accompanying Consolidated Balance Sheets. Restricted Cash - Non-current is included in Other Noncurrent Assets, net in the accompanying Consolidated Balance Sheets.

Restrictions on Cash and Cash Equivalents

	December 31,
	2023		2022
Cash and Cash Equivalents	$	199,371	$	273,070
Restricted Cash - Current(1)	43,897		40,366
Restricted Cash - Non-current(1)	—		13,516
Cash and Cash Equivalents and Restricted Cash	$	243,268	$	326,952

(1) Restricted Cash - Current is included in Other Current Assets in the accompanying Consolidated Balance Sheets. Restricted Cash - Non-current is included in Other Noncurrent Assets, net in the accompanying Consolidated Balance Sheets.

Debt Securities, Available-for-Sale

The Company's investments in available-for-sale securities are as follows:

	December 31, 2023
					Gross Unrealized
	Amortized Cost		Allowance for Credit Losses		Gains		Losses		Fair Value
U.S. Treasury Securities	$	81,829	$	—	$	103	$	—	$	81,932